March 30, 2020, IMV announced that its goal was to initiate a human trial “in the summer of 2020”.

  • On May 15, 2020, IMV announced that a Phase 1 human study was “expected this summer”.

  • On July 14, 2020, IMV claimed “rapid progress on COVID-19 vaccine program” and announced that it planned to commence Phase 1 clinical trials in the summer of 2020 with results in the fall of 2020, and phase 2 clinical trials commencing in the second half of 2020.

  • On August 5, 2020, IMV announced that it had received government funding and planned to use that funding with a Phase 1 trial starting summer 2020, with a Phase 2 trial expected to start by end of 2020.

  • On August 19, 2020, IMV stated that it was looking forward to reporting preliminary Phase 1 results “later this fall”.

  • On October 8, 2020, IMV provided an update on its COVID-19 vaccine program, stating that it had “decided to combine its original Phase 1 and 2 studies into a single trial with the potential to accelerate the clinical development and the timeline of the overall project.” IMV stated that “the Phase 1/2 trial is expected to be initiated before the end of 2020...”

  • The outlook was further revised on December 28, 2020, with IMV stating that “the Company is planning to conduct complementary preclinical studies…”

  • As of March 17, 2021, IMV was still “conducting complementary preclinical studies, including evaluating the impact of new variants, and will provide an update once these preclinical studies are completed.”

  • On May 12, 2021, IMV revised this disclosure to note that it was continuing its preclinical studies “at the request of the Canadian regulatory authorities”.

IMV has provided no further updates regarding the Phase 1/2 studies that were supposed to have been commenced last year, or any other updates regarding its attempts to develop a COVID-19 vaccine since.

IMV’s share price since it first announced plans to develop a COVID-19 vaccine reflects both the initial excitement about that program and the lack of progress since summer 2020